Table I.
Clinicopathological characteristic | n (%) |
---|---|
Sex | |
Male | 32 (45.7) |
Female | 38 (54.3) |
Age | |
Median, years | 65 |
Range, years | 34-89 |
≤60 years | 28 (40.0) |
>60 years | 42 (60.0) |
Curative resection | |
Yes | 13 (18.6) |
No | 57 (81.4) |
Imatinib therapy | |
Yes | 70 (100.0) |
No | 0 (0.0) |
Outcome | |
Alive | 21 (30.0) |
Dead | 49 (70.0) |
Primary tumour location | |
Oesophagus | 2 (2.9) |
Stomach | 33 (47.1) |
Small intestine | 25 (35.7) |
Rectum | 6 (8.6) |
Extraluminal | 4 (5.7) |
Mitotic index,/50 HPF | |
≤5 | 22 (31.4) |
5.1-10 | 11 (15.7) |
>10 | 37 (52.9) |
Primary tumour size, cm | |
0-5 | 6 (8.5) |
5.1-10 | 23 (32.9) |
>10 | 37 (52.9) |
Unknown | 4 (5.7) |
Risk classificationa | |
High | 49 (70.0) |
Intermediate | 11 (15.7) |
Low | 9 (12.9) |
Very low | 1 (1.4) |
Morphology | |
Spindle cells | 47 (67.1) |
Epithelioid cells | 8 (11.5) |
Mixed cells | 15 (21.4) |
Risk groups for gastrointestinal tumours were adapted from Miettinen et al (4).